Related references
Note: Only part of the references are listed.Prophylactic Central Compartment Lymph Node Dissection in Papillary Thyroid Carcinoma: Clinical Implications Derived From the First Prospective Randomized Controlled Single Institution Study
D. Viola et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Impact of clinical risk scores and BRAF V600E mutation status on outcome in papillary thyroid cancer
Severine M. Niederer-Wuest et al.
SURGERY (2015)
Papillary Thyroid Cancer: Factors Involved in Restaging N1 Disease After Total Thyroidectomy and Radioactive Iodine Treatment
Adi Guy et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Prophylactic Central Neck Dissection in Differentiated Thyroid Cancer: An Assessment of the Evidence
David E. Gyorki et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Prophylactic central neck dissection for papillary thyroid cancer
M. Barczynski et al.
BRITISH JOURNAL OF SURGERY (2013)
A Systematic Review and Meta-Analysis of Prophylactic Central Neck Dissection on Short-Term Locoregional Recurrence in Papillary Thyroid Carcinoma After Total Thyroidectomy
Brian Hung-Hin Lang et al.
THYROID (2013)
Routine central neck dissection in differentiated thyroid carcinoma: A systematic review and meta-analysis
Cheng-Xiang Shan et al.
LARYNGOSCOPE (2012)
Thyroid Cancer and Lymph Node Metastases
Orlo H. Clark
JOURNAL OF SURGICAL ONCOLOGY (2011)
A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer
Aleksandra Popadich et al.
SURGERY (2011)
Prophylactic Central Neck Dissection and Local Recurrence in Papillary Thyroid Cancer: A Meta-analysis
Tarek Zetoune et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Clinical Impact of the Detection of BRAF Mutations in Thyroid Pathology: Potential Usefulness as Diagnostic, Prognostic and Theragnostic Applications
Sandra Lassalle et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions
Dada Handkiewicz-Junak et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
BRAF Mutation in Papillary Thyroid Carcinoma in a Japanese Population: Its Lack of Correlation with High-Risk Clinicopathological Features and Disease-Free Survival of Patients
Yasuhiro Ito et al.
ENDOCRINE JOURNAL (2009)
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
David S. Cooper et al.
THYROID (2009)
Clinical outcomes in older or younger patients with papillary thyroid carcinoma: Impact of lymphadenopathy and patient age
N. Wada et al.
EJSO (2008)
Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma
Stephane Bardet et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Micrometastases in thyroid cancer. An important finding?
Isaac M. Cranshaw et al.
SURGICAL ONCOLOGY-OXFORD (2008)
Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid -: A meta-analysis
Ju-Han Lee et al.
CANCER (2007)
Correlation between B-RAF(V600E) mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature
L. Fugazzola et al.
ENDOCRINE-RELATED CANCER (2006)
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer
MZ Xing et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Share Paper
